These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
209 related items for PubMed ID: 35209073
21. Discovery of Baicalin as NDM-1 inhibitor: Virtual screening, biological evaluation and molecular simulation. Shi C, Bao J, Sun Y, Kang X, Lao X, Zheng H. Bioorg Chem; 2019 Jul; 88():102953. PubMed ID: 31077911 [Abstract] [Full Text] [Related]
22. Structure-based virtual screening, molecular docking, and molecular dynamics simulation approaches for identification of new potential inhibitors of class a β-lactamase enzymes. Khademi Dehkordi M, Hoveida L, Fani N. J Biomol Struct Dyn; 2024 Jul; 42(11):5631-5641. PubMed ID: 37534493 [Abstract] [Full Text] [Related]
23. Aurones and derivatives as promising New Delhi metallo-β-lactamase (NDM-1) inhibitors. Caburet J, Verdirosa F, Moretti M, Roulier B, Simoncelli G, Haudecoeur R, Ghazi S, Jamet H, Docquier JD, Boucherle B, Peuchmaur M. Bioorg Med Chem; 2024 Jan 01; 97():117559. PubMed ID: 38109811 [Abstract] [Full Text] [Related]
24. Evolution of New Delhi metallo-β-lactamase (NDM) in the clinic: Effects of NDM mutations on stability, zinc affinity, and mono-zinc activity. Cheng Z, Thomas PW, Ju L, Bergstrom A, Mason K, Clayton D, Miller C, Bethel CR, VanPelt J, Tierney DL, Page RC, Bonomo RA, Fast W, Crowder MW. J Biol Chem; 2018 Aug 10; 293(32):12606-12618. PubMed ID: 29909397 [Abstract] [Full Text] [Related]
25. A quantum mechanics/molecular mechanics study on the hydrolysis mechanism of New Delhi metallo-β-lactamase-1. Zhu K, Lu J, Liang Z, Kong X, Ye F, Jin L, Geng H, Chen Y, Zheng M, Jiang H, Li JQ, Luo C. J Comput Aided Mol Des; 2013 Mar 10; 27(3):247-56. PubMed ID: 23456591 [Abstract] [Full Text] [Related]
27. Inhibitor and substrate binding by New Delhi metallo-beta-lactamase-1: a molecular dynamics studies. Wang YT, Lu CY, Hour TC, Cheng TL. Curr Comput Aided Drug Des; 2014 Mar 10; 10(3):197-204. PubMed ID: 25479381 [Abstract] [Full Text] [Related]
28. Computationally designed peptide macrocycle inhibitors of New Delhi metallo-β-lactamase 1. Mulligan VK, Workman S, Sun T, Rettie S, Li X, Worrall LJ, Craven TW, King DT, Hosseinzadeh P, Watkins AM, Renfrew PD, Guffy S, Labonte JW, Moretti R, Bonneau R, Strynadka NCJ, Baker D. Proc Natl Acad Sci U S A; 2021 Mar 23; 118(12):. PubMed ID: 33723038 [Abstract] [Full Text] [Related]
29. Broad-Spectrum Inhibitors against Class A, B, and C Type β-Lactamases to Block the Hydrolysis against Antibiotics: Kinetics and Structural Characterization. Farhat N, Gupta D, Ali A, Kumar Y, Akhtar F, Kulanthaivel S, Mishra P, Khan F, Khan AU. Microbiol Spectr; 2022 Oct 26; 10(5):e0045022. PubMed ID: 36069578 [Abstract] [Full Text] [Related]
33. The activity and mechanism of vidofludimus as a potent enzyme inhibitor against NDM-1-positive E. coli. Li X, Zhao D, Zhao X, Cheng P, Li F, Sun J, Li Y, Bai J, Zhang X. Eur J Med Chem; 2023 Mar 15; 250():115225. PubMed ID: 36870273 [Abstract] [Full Text] [Related]
34. Pharmacophore-Based Study: An In Silico Perspective for the Identification of Potential New Delhi Metallo-β-lactamase-1 (NDM-1) Inhibitors. Alkhatabi HA, Alatyb HN. Pharmaceuticals (Basel); 2024 Sep 09; 17(9):. PubMed ID: 39338345 [Abstract] [Full Text] [Related]
36. In-silico screening of Acacia pennata and Bridelia retusa reveals pinocembrin-7-O-β-D-glucopyranoside as a promising β-lactamase inhibitor to combat antibiotic resistance. Umar AK, Roy D, Abdalla M, Modafer Y, Al-Hoshani N, Yu H, Zothantluanga JH. J Biomol Struct Dyn; 2024 Oct 09; 42(17):8800-8812. PubMed ID: 37587843 [Abstract] [Full Text] [Related]